XEN1101

· Xenon Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for XEN1101, covering 2024-09-19 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study of XEN1101 in Epilepsy [Phase 3]